Results 181 to 190 of about 20,482 (221)
Some of the next articles are maybe not open access.

Benign Monoclonal Gammopathy

Archives of Internal Medicine, 1982
SCOT Hickman, MD, Assistant Professor in Medicine, Washington University School of Medicine, St Louis: A 73-year-old man was referred to the hematology clinic in January 1979 for evaluation of hyperglobulinemia detected at a routine visit to his private physician. The serum total protein level at that time was 9.1 g/dL with an albumin level of 4.4 g/dL.
openaire   +2 more sources

Monoclonal gammopathies in children

Journal of Clinical Immunology, 1989
Over a 10-year period sera of 4000 pediatric patients were subjected to agar gel electrophoresis and immunoelectrophoresis. Retrospective examination of the electrophoresis patterns indicated that single or multiple homogeneous immunoglobulin components were present in sera of 155 children (3.9%).
E, Gerritsen   +5 more
openaire   +2 more sources

Neuropathy and monoclonal gammopathy

Current Opinion in Neurology, 2001
The association of neuropathy with monoclonal gammopathy has been known for several years, even if the nosological position of these neuropathies is still debated. Similarly unsettled is the pathogenetic role and diagnostic relevance in clinical practice of the antineural antibodies frequently associated with monoclonal gammopathies of undetermined ...
E. Nobile-Orazio, M. Carpo
openaire   +3 more sources

Monoclonal gammopathy with hyperlipidemia

The American Journal of Medicine, 1970
A sixty year old man was found to have a monoclonal gammopathy, probably due to multiple myeloma, associated with markedly elevated serum cholesterol and total lipid levels. There were no xanthomas. A low fat, low carbohydrate diet had no effect on the hyperlipidemia. There was no familial hyperlipidemia. The patient later died of heart failure.
F L, Ozer   +3 more
openaire   +2 more sources

Monoclonal gammopathy and neuropathy

Current Opinion in Neurology, 2007
To provide clinically useful guidelines in the management of neuropathy associated with monoclonal gammopathy from a review of the most recent literature and our own experience.Recent data on neuropathy associated with monoclonal gammopathy come from better descriptions of subgroups, and from new treatment compounds that have shown encouraging results ...
Pierre, Lozeron, David, Adams
openaire   +2 more sources

Monoclonal gammopathy and neuropathy

Current Opinion in Neurology, 2009
The management of peripheral neuropathy associated with monoclonal gammopathies has been advanced by recent clinical studies. We review the causal association between monoclonal gammopathy and neuropathy, and critically review the recent evidence on treatment.IgM monoclonal gammopathy of undetermined significance (MGUS) is the most commonly found ...
Sindhu, Ramchandren, Richard A, Lewis
openaire   +2 more sources

Spondylarthritis and monoclonal gammopathy

Joint Bone Spine, 2012
Joint Bone Spine - In Press.Proof corrected by the author Available online since mercredi 28 mars ...
Daniel, Wendling   +4 more
openaire   +2 more sources

[Monoclonal gammopathies].

Ugeskrift for laeger, 2021
Monoclonal gammopathies range from benign conditions to severe malignancies. A summary is given in this review. Overall, the prevalence is high; monoclonal gammopathies (MGUS) occur in > 3% of persons above 50 years of age. Approximately 400 new cases of multiple myeloma and 80 new cases of amyloid light-chain (AL) amyloidosis are diagnosed yearly in ...
openaire   +1 more source

An acute monoclonal gammopathy?

Annales de biologie clinique, 2015
Serum protein electrophoresis is commonly used in case of acute or chronic renal failure. It can lead to the etiologic diagnosis by detecting monoclonal gammopathies which are frequently complicated by renal failure, such as cast nephropathy, Randall's disease or amyloidosis, or to explore an associated inflammatory syndrome.
Alexandra, Presle   +5 more
openaire   +2 more sources

'Benign' Monoclonal Gammopathy

JAMA, 1984
A series of 241 patients with monoclonal protein but no evidence of multiple myeloma, macroglobulinemia, amyloidosis, or lymphoma (benign monoclonal gammopathy) were followed up for more than ten years. The patients were classified as follows: group 1, patients without increase of monoclonal serum protein during follow-up (benign) (37%); group 2 ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy